7-Substituierte Chinolon- und Naphthyridoncarbonsäure-Derivate
申请人:BAYER AG
公开号:EP0343398A2
公开(公告)日:1989-11-29
Die Erfindung betrifft 7-Aryl- und 7-Hetaryl-substituierte 'Chinolon- und Naphthyridoncarbonsäure-Derivate der allgemeinen Formel I
in der R1, R2, X2, X3, A und Y die in der Beschreibung angegebene Bedeutung haben, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel.
本发明涉及通式 I 的 7-芳基和 7-己基取代的喹啉酮和萘二甲酸衍生物。
中 R1、R2、X2、X3、A 和 Y 的含义,以及制备它们的工艺和含有它们的抗菌剂。
GILLIGAN, PAUL J.;MCGUIRK, PAUL R.;WITTY, MICHAEL J.
作者:GILLIGAN, PAUL J.、MCGUIRK, PAUL R.、WITTY, MICHAEL J.
DOI:——
日期:——
——
作者:GILLIGAN P. J.、 MCGUIRK P. R.、 WITTY M. J.
DOI:——
日期:——
Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest
申请人:Peng Jin
公开号:US20090306035A1
公开(公告)日:2009-12-10
Methods and compositions comprising chemical compounds that modulate the silencing of a polynucleotide of interest in a cell are provided. Such chemical compounds when used in combination with an appropriate silencing element can be used to modulate (increase or decrease) the level of the polynucleotide targeted by the silencing element. Methods of using such compositions both in therapies involving RNAi-mediated suppression of gene expression, as well as, in vitro methods that allow for the targeted modulation of expression of a polynucleotide of interest are provided. Pharmaceutical or cosmetic formulations comprising such compounds and silencing elements also are disclosed. Methods for screening a compound of interest for the ability to modulate the activity of a heterologous silencing element also are provided.